Abstract
The poly ADP ribose polymerase olaparib is currently approved in front line BRCA-associated epithelial ovarian cancer (EOC), platinum-sensitive recurr......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
